Prestige Consumer (NYSE: PBH) SVP Rosado reports holding 10 common shares

Rhea-AI Filing Summary

Prestige Consumer Healthcare executive Jose Luis Rosado filed an initial insider ownership report. As of January 6, 2026, he beneficially owns 10 shares of common stock, held directly. Rosado serves as SVP – Quality & Regulatory Affairs. No derivative securities are reported.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rosado Jose Luis

Role See Remarks

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 10 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 01/29/2026 - 04:01 PM Learn about SEC filing dates

FAQ

Who is the insider reporting ownership in Prestige Consumer Healthcare (PBH)?

Jose Luis Rosado, a senior executive at Prestige Consumer Healthcare, filed this ownership report. He serves as SVP – Quality & Regulatory Affairs, indicating a key leadership role overseeing product quality and regulatory compliance for the company.

How many Prestige Consumer Healthcare (PBH) shares does Jose Luis Rosado own?

Jose Luis Rosado reports beneficial ownership of 10 shares of Prestige Consumer Healthcare common stock. These shares are listed as held directly, meaning they are not reported through any intermediary entity such as a trust or partnership.

What type of SEC filing did Prestige Consumer Healthcare insider Jose Luis Rosado submit?

Jose Luis Rosado submitted a Form 3, which is an initial statement of beneficial ownership. It discloses his starting position of Prestige Consumer Healthcare common shares as an officer subject to Section 16 reporting requirements under U.S. securities laws.

Does Jose Luis Rosado report any derivative securities of Prestige Consumer Healthcare (PBH)?

No derivative securities are listed for Jose Luis Rosado in this filing. The table for options, warrants, or other derivatives shows no entries, indicating only 10 directly held common shares are reported at this time.

What is Jose Luis Rosado’s role at Prestige Consumer Healthcare (PBH)?

In this filing, Jose Luis Rosado is identified as an officer of Prestige Consumer Healthcare. The remarks specify his title as SVP – Quality & Regulatory Affairs, highlighting responsibility for quality systems and regulatory matters across the company’s products.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rosado Jose Luis

(Last) (First) (Middle)

660 WHITE PLAINS RD., 2ND FL

(Street)

TARRYTOWN NY 10591

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/06/2026

3. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	10	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

SVP-Quality & Regulatory Affairs. Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Jose L. Rosado by William P'Pool Attorney-in-Fact pursuant to Power of Attorney dated January 20, 2026 on file with the Commission	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.